Downstream Issues Still Beset Production
To Protect the Bottom Line, Biomanufacturers Invest in Downstream Purification Technology
GEN Roundup: No Detail Is Too Small in Bioprocess Scaleup
A Change in Scale Can Change Everything
Amid Election Clamor, Research Issues Surface
Sounds of Science Podcast
10 Takeover Targets of 2016
Which Biopharmas Do Wall Street Watchers View As Top Buyout Candidates?
For full access to this article login to GEN Select now.
Turning Targets into Drug Products
Biofirms Find Broader Areas of Application for High-throughput Techniques
- High-throughput approaches that have made an enormous difference in compound screening are beginning to make inroads into the broader area of drug discovery and development. In this arena, though, the term high throughput is relative. “For in vitro screening, hundreds of thousands of compounds screened with a 1,536-well plate ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.